The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of neoadjuvant PARP inhibition followed by radical prostatectomy (RP) in patients with unfavorable intermediate-risk or high-risk prostate cancer with BRCA1/2 gene alterations (NePtune).
 
Yu-Wei Chen
Employment - Amgen (I)
Stock and Other Ownership Interests - Amgen (I)
Honoraria - Eisai; Janssen; OncLive/MJH Life Sciences
Consulting or Advisory Role - Eisai
Travel, Accommodations, Expenses - DAVA Oncology
 
Lin Liu
No Relationships to Disclose
 
Yuwei Cheng
No Relationships to Disclose
 
Arlene Araneta
No Relationships to Disclose
 
Neremiah Castano
No Relationships to Disclose
 
Jennifer Gomez
No Relationships to Disclose
 
Archana Ajmera
Honoraria - NCCN
Consulting or Advisory Role - Astellas Pharma; Eisai; Nexus Pharmaceuticals Inc
 
Huihui Ye
No Relationships to Disclose
 
Karie Runcie
Consulting or Advisory Role - Johnson & Johnson/Janssen
 
Deaglan McHugh
Honoraria - OncLive
Consulting or Advisory Role - Progenics
 
Kenneth Offit
No Relationships to Disclose
 
Channing Paller
Consulting or Advisory Role - AstraZeneca; Bayer; Dendreon; Exelixis; Janssen Oncology; Omnitura; Pfizer
Research Funding - Lilly (Inst)
Travel, Accommodations, Expenses - Bayer; Bayer; Bayer
 
Naomi Haas
Consulting or Advisory Role - Eisai; Merck Sharp & Dohme
 
Robert Franklin
No Relationships to Disclose
 
Roberto Pili
Research Funding - ESSA (Inst)
 
Juan Javier-Desloges
No Relationships to Disclose
 
Christopher Kane
No Relationships to Disclose
 
Tyler Seibert
Stock and Other Ownership Interests - CorTechs Labs
Honoraria - Janssen
Consulting or Advisory Role - CorTechs Labs
Research Funding - GE Healthcare (Inst); Quibim (Inst)
Travel, Accommodations, Expenses - Janssen
 
Aditya Bagrodia
Consulting or Advisory Role - Ferring; Veracyte
 
Rana McKay
Consulting or Advisory Role - Ambrx; Ambrx; Arcus Biosciences; Astellas Medivation; AstraZeneca; AVEO; Bayer; Blue Earth Diagnostics; Bristol-Myers Squibb; Calithera Biosciences; Caris Life Sciences; Dendreon; Esiai; Exelixis; Janssen; Lilly; Merck; Myovant Sciences; NeoMorph; Novartis; Pfizer; Sanofi; Seagen; Sorrento Therapeutics; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tempus; Vividion Therapeutics
Research Funding - Artera (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol Myers Squibb (Inst); Exelixis (Inst); Oncternal Therapeutics (Inst); Tempus (Inst)